CLO26-085: CAR-T vs Bispecific Antibodies in DLBCL: Three-Month Safety Outcomes

Published in: Journal of the National Comprehensive Cancer Network

Volume 24, Issue 3.5

DOI: 10.6004/jnccn.2025.7435